Martingale Asset Management L P Collegium Pharmaceutical, Inc Transaction History

Martingale Asset Management L P

$4.27 Billion
Q3 2024

A detailed history of Martingale Asset Management L P transactions in Collegium Pharmaceutical, Inc stock. As of the latest transaction made, Martingale Asset Management L P holds 39,787 shares of COLL stock, worth $1.22 Million. This represents 0.04% of its overall portfolio holdings.

Number of Shares

39,787

Previous 39,496 0.74%

Holding current value

$1.22 Million

Previous $1.27 Million 20.93%

% of portfolio

0.04%

Previous 0.03%

23 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 14, 2024	BUY	$31.4 - $39.07 $9,137 - $11,369	291 Added 0.74%	39,787 $1.54 Million
Q2 2024 Aug 12, 2024	SELL	$31.36 - $39.99 $3,136 - $3,999	-100 Reduced 0.25%	39,496 $1.27 Million
Q1 2024 May 14, 2024	BUY	$31.23 - $40.91 $3,341 - $4,377	107 Added 0.27%	39,596 $1.54 Million
Q4 2023 Feb 12, 2024	BUY	$21.16 - $30.8 $9,818 - $14,291	464 Added 1.19%	39,489 $1.22 Million
Q3 2023 Nov 14, 2023	BUY	$21.23 - $24.28 $8,492 - $9,712	400 Added 1.04%	39,025 $872,000
Q2 2023 Aug 11, 2023	BUY	$21.06 - $24.0 $92,685 - $105,624	4,401 Added 12.86%	38,625 $830,000
Q1 2023 May 12, 2023	BUY	$23.0 - $29.88 $139,288 - $180,953	6,056 Added 21.5%	34,224 $821,000
Q4 2022 Feb 13, 2023	BUY	$16.14 - $23.55 $62,219 - $90,785	3,855 Added 15.86%	28,168 $653,000
Q3 2022 Nov 14, 2022	BUY	$15.46 - $20.1 $121,933 - $158,528	7,887 Added 48.02%	24,313 $390,000
Q2 2022 Aug 11, 2022	BUY	$14.22 - $20.88 $5,588 - $8,205	393 Added 2.45%	16,426 $291,000
Q1 2022 May 12, 2022	BUY	$17.2 - $22.5 $275,767 - $360,742	16,033 New	16,033 $326,000
Q3 2021 Nov 12, 2021	SELL	$17.75 - $25.39 $177,748 - $254,255	-10,014 Closed	0 $0
Q2 2021 Aug 13, 2021	SELL	$21.74 - $25.28 $143,831 - $167,252	-6,616 Reduced 39.78%	10,014 $236,000
Q1 2021 May 13, 2021	SELL	$19.25 - $26.1 $5,775 - $7,830	-300 Reduced 1.77%	16,630 $394,000
Q4 2020 Feb 10, 2021	SELL	$17.83 - $22.29 $1.06 Million - $1.32 Million	-59,288 Reduced 77.79%	16,930 $339,000
Q3 2020 Nov 12, 2020	BUY	$15.78 - $20.82 $708,742 - $935,109	44,914 Added 143.48%	76,218 $1.59 Million
Q2 2020 Aug 10, 2020	SELL	$15.49 - $23.51 $511 - $775	-33 Reduced 0.11%	31,304 $547,000
Q1 2020 May 11, 2020	BUY	$13.89 - $25.45 $435,270 - $797,526	31,337 New	31,337 $511,000
Q4 2019 Feb 10, 2020	SELL	$10.7 - $22.24 $1.03 Million - $2.13 Million	-95,965 Closed	0 $0
Q3 2019 Nov 13, 2019	BUY	$10.16 - $13.28 $975,004 - $1.27 Million	95,965 New	95,965 $1.1 Million
Q2 2019 Aug 13, 2019	SELL	$10.62 - $16.59 $621,737 - $971,244	-58,544 Closed	0 $0
Q1 2019 May 08, 2019	BUY	$13.58 - $18.72 $9,655 - $13,309	711 Added 1.23%	58,544 $0
Q4 2018 Feb 11, 2019	BUY	$14.78 - $19.68 $854,771 - $1.14 Million	57,833 New	57,833 $992,000

Others Institutions Holding COLL

# of Institutions

256

Shares Held

38.6M

Call Options Held

100K

Put Options Held

21.1K

View Full List

About COLLEGIUM PHARMACEUTICAL, INC

Ticker COLL
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 34,126,200
Market Cap $1.05B
Description
Collegium Pharmaceutical, Inc., a specialty pharmaceutical company, develops and commercializes medicines for pain management. Its portfolio includes Xtampza ER, an abuse-deterrent, extended-release, oral formulation of oxycodone; Nucynta ER and Nucynta IR, which are extended-release and immediate-release formulations of tapentadol; and Xtampza ...

More about COLL

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Martingale Asset Management L P, based on Form 13F filings with the SEC.

News

Stay updated on Martingale Asset Management L P with notifications on news.

Account

Martingale Asset Management L P Collegium Pharmaceutical, Inc Transaction History